The intraocular lens market was worth $4.6 billion worldwide in 2024 and is projected to reach $5.6 billion by 2034.

BVI announced today that the FDA approved its FineVision HP trifocal intraocular lens (IOL) for cataract surgery.

BVI's FineVision HP trifocal IOL, approved by the FDA, enhances the US premium IOL market with advanced optic design for ...

The new approvals are the latest in Johnson & Johnson’s IOLs; the Company claims the new TECNIS Eyhance IOL can slightly extend the depth of focus and deliver better image contrast. The Food and Drug ...

Rayner's RayOne EMV Toric IOL received FDA approval after a successful pivotal IDE study, highlighting its rotational ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Swiss Advanced Vision (SAV-IOL) has announced the launch of Project R-TASC, set to disrupt the global intraocular lens (IOL) market. Cataracts are responsible ...

Patients implanted with the Tecnis Symfony OptiBlue IOL, which includes a violet light filter, reported fewer dysphotopsias ...

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

Please provide your email address to receive an email when new articles are posted on . In 2013, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, ...

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...